LMA Optimizer B.V. is thrilled to announce the official market introduction of LarynxLock, an innovative medical device for laryngeal mask airways (LMAs), across the Netherlands and Belgium. This critical market entry is facilitated through an exclusive strategic distribution partnership with Endomed B.V., a leading medical device supplier in the region.

Addressing a Critical Clinical Challenge

Laryngeal mask airway (LMA) leakage remains a significant challenge in anesthesia practice, potentially compromising ventilation, increasing the risk of unexpected difficult airway, and contributing to operating room inefficiency.

LarynxLock is a CE-marked medical device engineered to address this issue directly. Its patented design provides a secure and reliable airway solution, resulting in:

• Enhanced Patient Safety: Reliably solving LMA leakage during critical anesthesia procedures.
• Improved Operational Efficiency: Allowing for quicker and simpler airway management and reducing the need for switching airway devices.
• Sustainable Practice: Produced with a commitment to minimizing environmental impact, the device supports sustainable clinical practices through its low carbon footprint.

Strategic Market Entry: Partnering with Endomed B.V.

Following the successful completion of our first commercial production batch, LMA Optimizer B.V. sought a partner capable of providing robust and reliable distribution to anesthesia professionals. Starting with the Netherlands and Belgium, Endomed B.V. is the ideal partner to share the clinical benefits of LarynxLock with their deep market expertise and respected position in the medical community.

Ready to experience a simpler and quicker airway management?

Visit our website for clinical data and product information: www.larynxlock.com

Order directly today through our exclusive distributor, Endomed B.V.: https://www.endomed.nl/nl/larynxlock-lekkagefixatie-voor-larynxmaskers.html